Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Pipeline
Amgen Science
Amgen Competitive Grants
Biosimilars
Overview
About Clinical Trails
Amgen Clinical Trails
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
Corporate Responsibility
Strategy & Governance
Overview
Amgen’s Commitment to Patients
Our Approach to Pricing,
Access and Affordability
Transformative Treatments, Approaches, and Technology
Access to Medicine
Amgen Foundation
Overview
Amgen Inspires
Amgen Foundation Grants
About the Amgen Foundation
Commitment to Community
Overview
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients
Diversity, Inclusion and Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Overview
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Workplace
Overview
Archived Reports
Summary of Data
CDP
Stakeholder Engagement
Stories
Newsroom
Investors
Careers
Overview
Amgen History
Mission and Values
Leadership
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Overview
Overview <i class="fa fa-external-link"></i>
Pipeline <i class="fa fa-external-link"></i>
Amgen Competitive Grants <i class="fa fa-external-link"></i>
Scientific Community Initiatives
Overview
Innovation
Quality
Reliability
Overview
Medical Information
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Overview
Corporate Responsibility <span class="mobile-menu-break"></span>Strategy & Governance
Our Approach to Pricing, <span class="mobile-menu-break"></span>Access and Affordability
Access to Medicine
Amgen Foundation
Commitment to Community
Diversity, Inclusion and Belonging
Environment
Responsible Sourcing
Workplace
Overview
Archived Reports
Summary of Data
CDP
Stakeholder Engagement
Over Amgen
Overzicht
Amgen in Nederland
Missie & Waarden
Visie Amgen Nederland
Transparantie
Geschiedenis
Ziektebeelden
Contact
Wetenschap
Overzicht
Amgen pijplijn
Over biotechnologie
Immuno-oncologie
Klinisch onderzoek in Nederland
Amgen biosimilars
Biomarkers bij longkanker
Producten
Overzicht
Onze geneesmiddelen
Onze zorgoplossingen
Risicominimalisatiematerialen
Amgen Biosimilars
Medische informatie
Maatschappij
Overzicht
Amgen ESG rapport
Amgen Foundation
Goede doelen
Diversity, Inclusion & Belonging
Duurzaamheid
Code VIG
Onze waarden
Vitaliteit @ Amgen
Verhalen
Werken bij Amgen
Media
ENGLISH
Home
>
Verhalen
>
Blogs
>
Blogs Stories
Blogs
02.16.2021
Blog Ronald: Data is wat ervaring vroeger was
Patiënten
Uitkomstgerichte oplossingen
Maatschappij
Blogs
Patiënten
Uitkomstgerichte oplossingen
Maatschappij
Blogs
Blogs
06.14.2023
Blog Ronald: Data is wat ervaring vroeger was
Blogs
04.05.2023
Interview General Manager Amgen Nederland en nieuw VIG-bestuurslid Carolina Correa
Blogs
12.31.2022
Blog Joep Rijnierse: Obstakels overwinnen, let’s go!
Blogs
01.01.2022
Blog Vincent: De focus op patiënt-relevante uitkomsten, dat willen we toch allemaal?
Blogs
01.01.2021
Blog Phi-Ngan: De osteoporose zorg moet én kan beter
Blogs
01.01.2021
Blog Peter de Vries: De band met Amgen wordt alleen maar sterker
Blogs
01.01.2020
Blog Jenny: Duidelijke taal voor patiënten
Blogs
05.21.2019
Blog Joep: Wij geven niet op
Blogs
05.21.2018
Blog Wil: Wij geven niet op
Blogs
05.21.2018
Blog Jeroen: Wij geven niet op
Blogs
05.21.2018
Blog Joep: Versnellen en opschalen
Blogs
05.21.2017
Blog Chris: Wij geven niet op